E. González

Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.

M. Dueñas, P. Sánchez‐Rovira, A. Lozano, 2000, Clinical breast cancer.

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

J. Feliu, A. Pèlegrin, M. González-Barón, 2005, British Journal of Cancer.

P1-14-03: AVALUZ Study: First Line with Bevacizumab in Combination with Paclitaxel (P) and Gemcitabine (G) in Patients with HER-2 Negative Recurrent or Metastatic BC: PFS Analysis.

C. Jara, E. Ciruelos, J. Baena, 2011 .

Preliminary results from an early phase II combination of gemcitabine and taxol in metastatic breast cancer

P. Sánchez‐Rovira, M. A. Moreno, A. Lozano, 1997 .